An Overview on Arsenic Trioxide-Induced Cardiotoxicity
An Overview on Arsenic Trioxide-Induced Cardiotoxicity
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Arsenic trioxide (ATO) is among the first-line chemotherapeutic drugs used in oncological practice. It has shown substantial efficacy in treating patients with relapsed or refractory acute promyelocytic leukaemia. The clinical use of ATO is hampered due to cardiotoxicity and hence many patients are precluded from receiving this highly effective tre...
Alternative Titles
Full title
An Overview on Arsenic Trioxide-Induced Cardiotoxicity
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2165099962
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2165099962
Other Identifiers
ISSN
1530-7905
E-ISSN
1559-0259
DOI
10.1007/s12012-018-09504-7
